In this video, Bruce Sands, MD, MS, from the Icahn School of Medicine at Mount Sinai, discusses when a gastroenterologist should recommend a JAK inhibitor for the treatment of ulcerative colitis.
Jeff Hutchins, PhD, discusses current clinical trials that are investigating whether some patients with non-small cell lung cancer may qualify for an immune-oncology therapy treatment regimen that is...
James Matera, MD, talks about the association between cardiometabolic diseases and hyperkalemia, the benefits and risks of various treatment approaches for chronic hyperkalemia, and more.
